²©Ô´¹ú¼Ê

Ͷ×ÊÕß¹Øϵ

INVESTOR RELATIONS

ÎÒ¹ú¿Æѧ¼ÒʵÏÖÑ×Ö¢Ïà¹ØmRNAÌåÄÚʵʱ¶¯Ì¬³ÉÏñ¼°ÔçÆÚÕï¶Ï

ȪԴ£ºÖйúÉúÎïÊÖÒÕÉú³¤ÖÐÐÄ

 

RNA¿Éͨ¹ý¸Ä±ä±í´ïºÍ¶¨Î»À´µ÷¿ØÑ×Ö¢±¬·¢¡¢Éú³¤ºÍÏûÍË £¬ÊÇÑ×Ö¢Àú³ÌÖеÄÒªº¦µ÷¿ØÒò×Ó £¬È»¶ø½«‍RNA‍×÷ΪÉúÎï±ê¼ÇÎïÓÃÓÚÑ×Ö¢µÄÌåÄÚ¹âѧ³ÉÏñÉÐδ»ñµÃ֤ʵ¡£½üÆÚ £¬¹ú¼ÒÄÉÃ׿ÆѧÖÐÐĵĿÆÑÐÍŶÓʵÏÖÁËÑ×Ö¢Ïà¹ØmRNAÌåÄÚʵʱ¶¯Ì¬³ÉÏñ¼°ÔçÆÚÕï¶Ï¡£Ïà¹ØЧ¹ûÔÚ¡¶Nature Biomedical Engineering¡·½ÒÏþ £¬ÂÛÎĵÄÎÊÌâΪ“Spatially resolved in vivo imaging of inflammation-associated mRNA via enzymatic fluorescence amplification in a molecular beacon”¡£

¿ÆÑÐÍŶÓÉè¼Æ²¢¹¹½¨ÁËÒ»ÖÖ»ùÓÚø´¥·¢ÐÍ·Ö×ÓÐűêµÄÑ×֢ϸ°ûÌØÒìÐÔÐźŷŸÅÂÔÁì £¬Í¨¹ý¿Õ¼äÑ¡ÔñÐÔ·Å´óÑ×Ö¢Ïà¹Ø‍RNA‍³ÉÏñÐźŠ£¬ÊµÏÖÁËÑ×Ö¢Ïà¹Ø‍mRNA‍µÄ¸ßÐű³±È³ÉÏñ¡£¸ÃÑо¿Í¨¹ý¼ì²âСÊóצ×ÓÖеļ±ÐÔÑ×Ö¢ºÍ¸ÎÔàÖÐÒ©ÎïÓÕµ¼µÄÑ×Ö¢ £¬ÆÀ¹ÀÁË°ÐÏò°×ϸ°û½éËØ-6£¨IL-6£©mRNAµÄ¹¤³Ì·Ö×ÓÐűêÔÚ»îСÊóÖеÄÃô¸ÐÐÔºÍ×éÖ¯ÌØÒìÐÔ¡£Ñо¿Ö¤ÊµÕâÖÖø´ÙÀ©ÔöÕ½ÂÔ¿ÉÒÔÔÚÌåÄÚ¶ÔÆäËûÓë¼²²¡Ïà¹ØµÄRNA¾ÙÐÐÌØÒìÐÔºÍѸËٵijÉÏñ¡£

¸ÃÑо¿ÎªÑ×Ö¢Ïà¹Øm‍RNA‍¸ßѸËÙ³ÉÏñÌṩÁËÒ»ÖÖÐÂÒªÁì £¬ÓÐÖúÓÚʵʱ¼à²âÑ×Ö¢ºÍÕï¶ÏÒ©ÎïÓÕµ¼µÄ¶¾ÐÔ £¬ÓÐÍûÓ¦ÓÃÓÚÑ×Ö¢Ïà¹Ø¼²²¡µÄÔçÆÚÕï¶Ï¼°ÖÎÁÆÀú³ÌµÄʵʱÆÀ¼Û¡£

 

×¢£º´ËÑо¿Ð§¹ûÕª×Ô¡¶Nature Biomedical Engineering¡·ÆÚ¿¯ £¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾¿´·¨ºÍ̬¶È £¬½ö¹©²Î¿¼¡£

ÍøÕ¾µØͼ